Alpa Laboratories Ltd

Alpa Laboratories Ltd has a market capitalization of INR 1,416,874,004 and a market price of INR 67.34 per share, with no dilution risk identified in the current period. The company has 21,040,600 basic and diluted shares outstanding, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's revenue in the latest period was INR 674,819,000, according to analyst estimates. While no direct comparison to industry medians is available, the company's revenue suggests a mid-sized presence in the pharmaceutical sector. The absence of profitability metrics such as ROIC, EBITDA margins, or net profit margins prevents a detailed assessment of returns relative to industry benchmarks. Alpa Laboratories operates in both human and veterinary pharmaceutical markets, with a diverse product portfolio including capsules, creams, ointments, ear and eye drops, and tablets for human use, and boluses and injections for veterinary use. The company's geographic exposure is primarily concentrated in India, with no disclosed international revenue segments. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is not clearly defined in the available data, as no forward-looking revenue estimates or historical growth rates are provided. Analysts have reported the latest actual revenue, but no projections for the current or next fiscal year are available to assess growth momentum. The company's risk profile includes a low dilution potential, with no evidence of recent or planned share issuance that would dilute existing shareholders. However, the absence of liquidity metrics and balance-sheet data limits the ability to assess financial stability. No recent filings or transcripts are available to identify material events or strategic shifts that could impact the company's operations or valuation. No recent events, such as earnings calls, regulatory filings, or strategic announcements, are available in the provided data to inform the company's current operational or financial status.